Has the patient had a documented clinical assessment for this cancer (SINCE SUBMISSION OF THE PREVIOUS FOLLOW-UP FORM)
Descripción
Documented clinical assessment for this cancer
Tipo de datos
text
Alias
NCI Thesaurus ValueDomain
C38148
UMLS CUI-1
C1522577
NCI Thesaurus Property
C16033
UMLS CUI-2
C0006826
NCI Thesaurus ObjectClass
C9305
NCI Thesaurus Property-2
C25365
Date
Descripción
Assessment Date
Tipo de datos
date
Alias
NCI Thesaurus ValueDomain
C25164
UMLS CUI-1
C2985720
NCI Thesaurus ObjectClass
C25367
NCI Thesaurus ValueDomain-2
C25367
NCI Thesaurus Property
C38000
Performance Status (ZUBROD 0-5, 9-UNKNOWN)
Descripción
ECOG Performance Status
Tipo de datos
text
Alias
NCI Thesaurus ValueDomain
C25664
UMLS CUI-1
C1520224
NCI Thesaurus Property
C25367
NCI Thesaurus ValueDomain-2
C25491
NCI Thesaurus ObjectClass
C20641
Unnamed Module 6
Descripción
Unnamed Module 6
Has the patient had a prostate biopsy (SINCE SUBMISSION OF THE LAST FOLLOW-UP FORM)
Descripción
Prostate Biopsy
Tipo de datos
text
Alias
NCI Thesaurus ObjectClass
C15189
UMLS CUI-1
C0194804
NCI Thesaurus ObjectClass-2
C12410
NCI Thesaurus Property
C38000
NCI Thesaurus ValueDomain
C25688
Biopsy Date
Descripción
Biopsy Date
Tipo de datos
date
Alias
NCI Thesaurus ValueDomain
C25164
UMLS CUI-1
C0005558
NCI Thesaurus ValueDomain-2
C25367
NCI Thesaurus ObjectClass
C15189
UMLS CUI-2
C0011008
NCI Thesaurus Property
C25275
Is the tumor palpable
Descripción
Palpable Tumor
Tipo de datos
text
Alias
NCI Thesaurus ValueDomain
C25180
UMLS CUI-1
C0746412
NCI Thesaurus ObjectClass
C3262
NCI Thesaurus Property
C25626
NCI Thesaurus ObjectClass-2
C25606
Unnamed Module 5
Descripción
Unnamed Module 5
Has the patient been diagnosed with biochemical recurrence since submission of the last follow-up form
Descripción
PSA Failure
Tipo de datos
text
Alias
NCI Thesaurus ValueDomain
C38148
UMLS CUI-1
C2985506
NCI Thesaurus Property
C25626
NCI Thesaurus ObjectClass
C25331
NCI Thesaurus ObjectClass-2
C25434
Has the patient been diagnosed with a first local recurrence (SINCE SUBMISSION OF LAST FOLLOW-UP FORM See Protocol Section 11)
Descripción
Neoplasm recurrence, Local
Tipo de datos
text
Alias
NCI Thesaurus ObjectClass
C19987
UMLS CUI-1
C0027643
NCI Thesaurus Property
C67263
NCI Thesaurus Property-2
C25509
NCI Thesaurus Property-3
C15220
NCI Thesaurus ValueDomain
C38148
Date
Descripción
Date of Neoplasm local recurrence
Tipo de datos
date
Alias
NCI Thesaurus ObjectClass
C3352
UMLS CUI-1
C0027643
NCI Thesaurus ObjectClass-2
C25388
UMLS CUI-2
C0011008
NCI Thesaurus Property
C25509
NCI Thesaurus Property-2
C15220
NCI Thesaurus ValueDomain
C25164
Other Specify
Descripción
Evaluation method, specify
Tipo de datos
text
Alias
NCI Thesaurus ValueDomain
C25685
UMLS CUI-1
C2911685
NCI Thesaurus ObjectClass
C20989
UMLS CUI-2
C1521902
NCI Thesaurus Property
C16847
Other Specify
Descripción
Evaluation method, specify
Tipo de datos
text
Alias
NCI Thesaurus ValueDomain
C25685
UMLS CUI-1
C2911685
NCI Thesaurus ObjectClass
C20989
UMLS CUI-2
C1521902
NCI Thesaurus Property
C16847
Has the patient been diagnosed with first distant progression (SINCE SUBMISSION OF THE LAST FOLLOW-UP FORM)
Descripción
Neoplasm recurrence, Distal
Tipo de datos
text
Alias
NCI Thesaurus ObjectClass
C19987
UMLS CUI-1
C0027627
NCI Thesaurus Property
C25321
NCI Thesaurus Property-2
C25509
NCI Thesaurus Property-3
C15220
NCI Thesaurus ValueDomain
C25180
Date
Descripción
Date of Neoplasm distal recurrence
Tipo de datos
date
Alias
NCI Thesaurus ValueDomain
C25164
UMLS CUI-1
C0027627
NCI Thesaurus ObjectClass
C25331
NCI Thesaurus ValueDomain-2
C25509
UMLS CUI-2
C0011008
NCI Thesaurus Property
C25275
Sites of Progression (First distant)
Descripción
Progression Sites
Tipo de datos
text
Alias
NCI Thesaurus ValueDomain
C25704
UMLS CUI-1
C0280457
NCI Thesaurus Property
C25341
NCI Thesaurus ObjectClass
C25331
Method of Evaluation (DISTANT PROGRESSION)
Descripción
Evaluation method
Tipo de datos
text
Alias
NCI Thesaurus ValueDomain
C25284
UMLS CUI-1
C2911685
NCI Thesaurus ObjectClass
C20989
NCI Thesaurus Property
C16847
Method of Evaluation (DISTANT PROGRESSION)
Descripción
Evaluation method
Tipo de datos
text
Alias
NCI Thesaurus ValueDomain
C25284
UMLS CUI-1
C2911685
NCI Thesaurus ObjectClass
C20989
NCI Thesaurus Property
C16847
Baseline Lab Values (hematologic)
Descripción
Baseline Lab Values (hematologic)
WBC (mm^3)
Descripción
Leukocytes (WBC)
Tipo de datos
float
Alias
NCI Thesaurus ObjectClass
C25294
UMLS CUI-1
C0023508
NCI Thesaurus Property
C12529
NCI Thesaurus Property-2
C20200
NCI Thesaurus ValueDomain
C38046
NCI Thesaurus ValueDomain-2
C25712
Hemoglobin (g/dL)
Descripción
LaboratoryProcedureHemoglobinResultSpecifiedValue
Tipo de datos
float
Unidades de medida
g/dL
Alias
NCI Thesaurus Property
C16676
UMLS 2011AA Property
C0019046
NCI Thesaurus Property-2
C20200
UMLS 2011AA Property-2
C1274040
NCI Thesaurus ObjectClass
C25294
UMLS 2011AA ObjectClass
C0022885
NCI Thesaurus ValueDomain
C25712
UMLS 2011AA ValueDomain
C1522609
g/dL
Peripheral Platelet Count (mm^3)
Descripción
Platelets
Tipo de datos
float
Unidades de medida
1000/uL
Alias
NCI Thesaurus Property
C20200
UMLS CUI-1
C0005821
NCI Thesaurus Property-2
C12520
NCI Thesaurus ObjectClass
C25294
NCI Thesaurus ValueDomain
C25712
1000/uL
Date (s)
Descripción
Laboratory Procedure Date
Tipo de datos
date
Alias
NCI Thesaurus ValueDomain
C25164
UMLS CUI-1
C0022885
NCI Thesaurus Property
C25214
UMLS CUI-2
C0011008
NCI Thesaurus Property-2
C38000
NCI Thesaurus ObjectClass
C25294
Date (s)
Descripción
Laboratory Procedure Date
Tipo de datos
date
Alias
NCI Thesaurus ValueDomain
C25164
UMLS CUI-1
C0022885
NCI Thesaurus Property
C25214
UMLS CUI-2
C0011008
NCI Thesaurus Property-2
C38000
NCI Thesaurus ObjectClass
C25294
Date (s)
Descripción
Laboratory Procedure Date
Tipo de datos
date
Alias
NCI Thesaurus ValueDomain
C25164
UMLS CUI-1
C0022885
NCI Thesaurus Property
C25214
UMLS CUI-2
C0011008
NCI Thesaurus Property-2
C38000
NCI Thesaurus ObjectClass
C25294
Date (s)
Descripción
Laboratory Procedure Date
Tipo de datos
date
Alias
NCI Thesaurus ValueDomain
C25164
UMLS CUI-1
C0022885
NCI Thesaurus Property
C25214
UMLS CUI-2
C0011008
NCI Thesaurus Property-2
C38000
NCI Thesaurus ObjectClass
C25294
ANC (mm^3)
Descripción
Neutrophil count
Tipo de datos
float
Alias
NCI Thesaurus ObjectClass
C25294
UMLS CUI-1
C0200633
NCI Thesaurus Property
C12533
NCI Thesaurus Property-2
C20200
NCI Thesaurus ValueDomain
C25304
NCI Thesaurus ValueDomain-2
C25712
Unnamed Module 4a
Descripción
Unnamed Module 4a
PSA Date (s)
Descripción
PSA date
Tipo de datos
date
Alias
NCI Thesaurus ObjectClass
C25294
UMLS CUI-1
C0138741
NCI Thesaurus Property
C17525
UMLS CUI-2
C0011008
NCI Thesaurus Property-2
C20200
NCI Thesaurus Property-3
C17220
NCI Thesaurus ValueDomain
C25164
NCI Thesaurus ValueDomain-2
C25367
PSA Value (s)
Descripción
PSA
Tipo de datos
float
Unidades de medida
ng/ml
Alias
NCI Thesaurus ObjectClass
C25294
UMLS CUI-1
C0138741
NCI Thesaurus Property
C17525
NCI Thesaurus Property-2
C20200
NCI Thesaurus Property-3
C17220
NCI Thesaurus ValueDomain
C25712
ng/ml
Units
Descripción
AssessmentLabUOM
Tipo de datos
text
Alias
NCI Thesaurus ObjectClass
C20989
UMLS 2011AA ObjectClass
C0031809
NCI Thesaurus Property
C37984
UMLS 2011AA Property
C0022877
NCI Thesaurus ValueDomain
C25709
UMLS 2011AA ValueDomain
C1519795
Method of Assay
Descripción
PSAManufacturerAssayType
Tipo de datos
text
Alias
NCI Thesaurus ValueDomain
C25284
UMLS 2011AA ValueDomain
C0332307
NCI Thesaurus ObjectClass
C17525
UMLS 2011AA ObjectClass
C0138741
NCI Thesaurus Property
C16341
UMLS 2011AA Property
C0005507
NCI Thesaurus Property-2
C25392
UMLS 2011AA Property-2
C0947322
Non-protocol Therapy
Descripción
Non-protocol Therapy
Is the patient receiving any non-protocol cancer therapy not previously reported (PROSTATE If yes, enter therapy type and date for each therapy delivered during the follow-up period.)
Descripción
Non-protocolTherapyAdministeredInd-3
Tipo de datos
text
Alias
NCI Thesaurus ValueDomain
C38148
UMLS 2011AA ValueDomain
C1512699
NCI Thesaurus ObjectClass
C15368
NCI Thesaurus ObjectClass-2
C25590
UMLS 2011AA ObjectClass
C1518384
NCI Thesaurus Property
C25382
UMLS 2011AA Property
C1521801
Non-Protocol Therapy Type
Descripción
Non-ProtocolTherapyAdministeredType
Tipo de datos
text
Alias
NCI Thesaurus ValueDomain
C25284
UMLS 2011AA ValueDomain
C0332307
NCI Thesaurus ObjectClass
C15368
NCI Thesaurus ObjectClass-2
C25590
UMLS 2011AA ObjectClass
C1518384
NCI Thesaurus Property
C25382
UMLS 2011AA Property
C1521801
Date of First Non-Protocol Therapy
Descripción
Non-ProtocolTherapyFirstAdministeredDate
Tipo de datos
date
Alias
NCI Thesaurus ObjectClass
C15368
NCI Thesaurus ObjectClass-2
C25590
UMLS 2011AA ObjectClass
C1518384
NCI Thesaurus Property
C25509
UMLS 2011AA Property
C1279901
NCI Thesaurus Property-2
C25382
UMLS 2011AA Property-2
C1521801
NCI Thesaurus ValueDomain
C25164
UMLS 2011AA ValueDomain
C0011008
NCI Thesaurus ValueDomain-2
C25367
Specify
Descripción
Non-ProtocolTreatmentFirstAdministeredSpecify
Tipo de datos
text
Alias
NCI Thesaurus ObjectClass
C15368
NCI Thesaurus ObjectClass-2
C25590
UMLS 2011AA ObjectClass
C1518384
NCI Thesaurus Property
C25509
UMLS 2011AA Property
C1279901
NCI Thesaurus Property-2
C25382
UMLS 2011AA Property-2
C1521801
NCI Thesaurus ValueDomain
C25685
UMLS 2011AA ValueDomain
C1521902
Unnamed Module 7
Descripción
Unnamed Module 7
Has a new primary cancer or MDS been diagnosed that has not been previously reported? (MYELODYSPLASTIC SYNDROME)
Fully Active, Able To Carry On All Pre-disease Performance Without Restriction. (0)
CL Item
Restricted In Physically Strenuous Activity But Ambulatory And Able To Carry Out Work Of A Light Or Sedentary Nature, E.g., Light Housework, Office Work. (1)
CL Item
Ambulatory And Capable Of All Selfcare But Unable To Carry Out Any Work Activities. Up And About More Than 50% Of Waking Hours. (2)
CL Item
Capable Of Only Limited Selfcare, Confined To Bed Or Chair More Than 50% Of Waking Hours. (3)
CL Item
Completely Disabled. Cannot Carry On Any Selfcare. Totally Confined To Bed Or Chair. (4)
Is the patient receiving any non-protocol cancer therapy not previously reported (PROSTATE If yes, enter therapy type and date for each therapy delivered during the follow-up period.)
Is the patient receiving any non-protocol cancer therapy not previously reported (PROSTATE If yes, enter therapy type and date for each therapy delivered during the follow-up period.)